Better Medicare Alliance encourages CMS to delay some proposed changes
By HME News Staff
Updated 11:32 AM CST, Wed March 9, 2022
WASHINGTON – The Better Medicare Alliance has issued comments in response to CMS’s 2023 Medicare Advantage and Part D Advance Notice and proposed rule, asking the agency to consider the full impact of maximum out-of-pocket costs. “As we heartily support CMS in many of these efforts, our comments also encourage the agency to consider the full impact of maximum out-of-pocket changes that could disproportionately impact plans that serve higher proportions of dual-eligible beneficiaries and curtail supplemental benefit offerings,” said Mary Beth Donahue, president and CEO. “Better Medicare Alliance additionally encourages CMS to consider a delay of its proposed pharmacy price concession changes, which could limit access to zero-dollar premium plans and raise costs for the 9 in 10 Medicare Advantage beneficiaries enrolled in an integrated MA-PD plan. We look forward to a final rule and rate announcement that preserves and strengthens Medicare Advantage for the more than 28 million satisfied, diverse beneficiaries counting on its coverage and care.” In its comments, the Better Medicare Alliance asks CMS to address: social determinants of health and advancing health equity, end-stage renal disease payment, web-based consumer assessment of health care providers and systems survey, maximum out-of-pocket limit, and pharmacy price concessions in the negotiated price.
Comments